Presenting the webinar will be Vincent Hsu, MD who is the Hospital Epidemiologist and Executive Director for Infection Prevention at Florida Hospital in Orlando
Wolters Kluwer Health, a leading global provider of information for healthcare professionals and students, is hosting a complimentary webinar with Vincent Hsu, MD in "Maintaining Preparedness for Emerging Infections Today and Tomorrow."
Our recent experience with Ebola virus, Chikungunya, Middle East Coronavirus syndrome (MERS), and a host of other pathogens previously unseen in the United States indicates that emerging infections anywhere have the potential to affect people everywhere. In addition, healthcare-associated and multidrug resistant infections are emerging infections that impact us right here, right now. Given these issues, what is the role that the healthcare provider plays in recognizing and managing these infections? What is the message we need to be telling our colleagues and the general public?
In this presentation, Hsu will provide tools to increase awareness on the types of EIDs that are occurring worldwide with potential impact within the United States, how to suspect and communicate with public health experts so that the disease can be managed and transmission can be minimized, and where the provider can keep up-to-date on the emerging trends worldwide.
Maintaining Preparedness for Emerging Infections Today and Tomorrow
Date: Wednesday, February 4, 2014
Time: 12:00 PM - 1:00 PM ET
About the Presenter
Vincent Hsu, MD is the Hospital Epidemiologist and Executive Director for Infection Prevention at Florida Hospital in Orlando. He also serves as an Assistant Director for the Florida Hospital Internal Medicine Residency Program with faculty appointments from both Florida State University and the University of Central Florida Colleges of Medicine. A 1995 graduate from the Loma Linda University School of Medicine, he completed his infectious disease training at the University of Southern California, and obtained a Master of Public Health at UCLA. He spent three years at the Centers for Disease Control and Prevention as an Epidemic Intelligence Officer participating in investigations into the 2001 anthrax attacks and 2003 SARS epidemic, with an emphasis on international outbreaks and public health research. He is board-certified in Infectious Disease and Preventive Medicine, and has published in several peer-reviewed journals. Dr. Hsu's areas of interest include prevention of hospital-associated infections, hospital preparedness for seasonal and pandemic influenza and strategies to improve patient safety.
About Wolters Kluwer Health
Wolters Kluwer Health is a leading global provider of information, business intelligence and point-of-care solutions for the healthcare industry. Serving more than 150 countries worldwide, clinicians rely on Wolters Kluwer Health's market leading information-enabled tools and software solutions throughout their professional careers from training to research to practice. Major brands include Health Language®, Lexicomp®, Lippincott Williams & Wilkins, Medicom®, Medi-Span®, Medknow, Ovid®, Pharmacy OneSource®, ProVation® Medical and UpToDate®.
Wolters Kluwer Health is part of Wolters Kluwer, a market-leading global information services company. Wolters Kluwer had 2013 annual revenues of €3.6 billion ($4.7 billion), employs approximately 19,000 people worldwide, and maintains operations in over 40 countries across Europe, North America, Asia Pacific, and Latin America. Wolters Kluwer is headquartered in Alphen aan den Rijn, the Netherlands. Its shares are quoted on Euronext Amsterdam (WKL) and are included in the AEX and Euronext 100 indices. Wolters Kluwer has a sponsored Level 1 American Depositary Receipt program. The ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Follow our official Twitter handle: @WKHealth.